Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 11/20 | 0.37 |
| ▸ | CTSK | P43235 | 9/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 2/20 | 0.36 |
| ▸ | CTSB | P07858 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30814967 | 0.95 | PTGS1 (0.38) | PTGS1GSTK1CTSSCTSKGLO1 | |
| SCHEMBL30814833 | 0.95 | PTGS1 (0.38) | PTGS1GSTK1CTSSCTSKGLO1 | |
| SCHEMBL30590004 | 0.87 | CTSS (0.46) | PTGS1GSTK1CTSSCTSKGLO1 | |
| SCHEMBL31142113 | 0.85 | PTGS1 (0.42) | PTGS1GSTK1CTSSCTSKGLO1 | |
| SCHEMBL30312625 | 0.85 | CTSS (0.52) | CTSSCTSKCYP2D6CTSLCTSB | |
| SCHEMBL18575874 | 0.84 | CYP2D6 (0.40) | CTSSCTSKCYP2D6CTSLCTSB | |
| SCHEMBL31142118 | 0.84 | CYP2D6 (0.40) | CTSSCTSKCYP2D6CTSLCTSB | |
| SCHEMBL22398218 | 0.84 | TDP1 (0.40) | CTSSCTSKCYP2D6TDP1 | |
| SCHEMBL22398216 | 0.84 | TDP1 (0.40) | CTSSCTSKCYP2D6TDP1 | |
| SCHEMBL22398629 | 0.82 | MEN1 (0.41) | CTSSCTSKCYP2D6CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2024-09-26 | — | — | US | disclosed |
| CN-117320759-A | Radiopharmaceutical somatostatin receptor ligands and precursors thereof | 慕尼黑工业大学 | 2023-12-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | SSTR1, SSTR3, SSTR4 | PTGS1 4765/4885GSTK1 4674/4885CTSS 2214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.